<p><b>(a)</b> Immunohistochemical staining of IGF-1R and Ki-67 (x400) in SCLC patient samples according to the expression level of IGF-1R. <b>(b)</b> Overall survival/disease-specific survival in SCLC according to low- and high-IGF-1R expression. <b>(c)</b> Disease-free survival in SCLC according to low- and high-IGF-1R expression.</p
<p>Survival outcome analysis of high or low immunohistochemical marker indices divided by median in ...
<p>The staining of SDR9C7 occurred in cytoplasm of cancer cells. a and b, ESCC tissues with lymph no...
<p>NSCLC subtypes were diagnosed by H&E on resection specimens (A) and by combined IHC classificatio...
<p>TMA of SCLC patients was immunohistochemically stained against CEA. Three patient groups were dis...
<p>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (−) exp...
<p>Tables below each graph show the numbers of patients at risk at various time points.</p
<p>The Log-rank test showed that the survival times were significantly longer in patients with low s...
<p>Kaplan-Meier survival curve estimates showing the effect of baseline IGF-1R expression (left) and...
Univariate and multivariate analyses for overall survival in the ED-SCLC patients (n = 141).</p
<p>The overall survival was lower in the IGF-1R negative group (83%) as compared to the IGF-1R posit...
<p><b>a</b> High expression of FGF9 stained in GC. <b>b</b> Low expression FGF9 stained in neighbori...
Univariate analysis of immunohistochemical markers of 3-year progression-free survival and 3-year ov...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>(A, B) Kaplan-Meier curves for overall survival (A) and recurrence-free survival (B) in patients ...
<p>L D<sup>1</sup> means Limited Disease and E D<sup>2</sup> means Extensive Disease.</p
<p>Survival outcome analysis of high or low immunohistochemical marker indices divided by median in ...
<p>The staining of SDR9C7 occurred in cytoplasm of cancer cells. a and b, ESCC tissues with lymph no...
<p>NSCLC subtypes were diagnosed by H&E on resection specimens (A) and by combined IHC classificatio...
<p>TMA of SCLC patients was immunohistochemically stained against CEA. Three patient groups were dis...
<p>Survival curves from the time of diagnosis for NSCLC patients with either high (+) or low (−) exp...
<p>Tables below each graph show the numbers of patients at risk at various time points.</p
<p>The Log-rank test showed that the survival times were significantly longer in patients with low s...
<p>Kaplan-Meier survival curve estimates showing the effect of baseline IGF-1R expression (left) and...
Univariate and multivariate analyses for overall survival in the ED-SCLC patients (n = 141).</p
<p>The overall survival was lower in the IGF-1R negative group (83%) as compared to the IGF-1R posit...
<p><b>a</b> High expression of FGF9 stained in GC. <b>b</b> Low expression FGF9 stained in neighbori...
Univariate analysis of immunohistochemical markers of 3-year progression-free survival and 3-year ov...
<p> (a) OS curves of SACC patients according to USP22 immunostaining; (b) DFS curves of SACC patient...
<p>(A, B) Kaplan-Meier curves for overall survival (A) and recurrence-free survival (B) in patients ...
<p>L D<sup>1</sup> means Limited Disease and E D<sup>2</sup> means Extensive Disease.</p
<p>Survival outcome analysis of high or low immunohistochemical marker indices divided by median in ...
<p>The staining of SDR9C7 occurred in cytoplasm of cancer cells. a and b, ESCC tissues with lymph no...
<p>NSCLC subtypes were diagnosed by H&E on resection specimens (A) and by combined IHC classificatio...